|
WO2016011559A1
|
|
Methods for atom incorporation into materials using a plasma afterglow
|
|
AU2015240392A1
|
|
Steric-hindrance hybridization systems, assays and methods associated thereto
|
|
EP2882342A1
|
|
Method and system for assessing a stimulus property perceived by a subject
|
|
US2015238083A1
|
|
Method and system for optically investigating a tissue of a subject
|
|
WO2014022922A1
|
|
Helmet for measurements
|
|
WO2013142994A1
|
|
Redox-active ionic liquids
|
|
AU2013200079A1
|
|
Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
|
|
WO2013023285A1
|
|
Azomethine compounds
|
|
AU2012202739A1
|
|
Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease
|
|
CA2775278A1
|
|
Arrestin biosensor
|
|
WO2011100841A1
|
|
Pd-1 modulation and uses thereof for modulating hiv replication
|
|
EP2160404A1
|
|
Azapeptides as cd36 binding compounds
|
|
EP2079430A1
|
|
System for improving a subject's sensory, reflex and/or motor mechanisms via auditory, tactile or visual stimulations
|
|
EP1943342A1
|
|
Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
|
|
US2009123953A1
|
|
Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
|
